Exosome release and neuropathology induced by α-synuclein: new insights into protective mechanisms of Drp1 inhibition.
Ontology highlight
ABSTRACT: Targeting alpha-synuclein (α-syn) as a therapeutic strategy for Parkinson's disease (PD) has been intensively pursued largely due to its well-recognized pathogenic role. Since its discovery as the first familial link to PD over two decades ago, this protein has been associated with multiple neurotoxic mechanisms, such as mitochondrial dysfunction and impaired autophagic flux. We report here that blocking dynamin-related protein 1 (Drp1) improved both mitochondrial function and autophagic flux in experimental models of α-syn. Using rat dopaminergic neuronal cells with inducible wild-type human α-syn, we observed excessive mitochondrial fragmentation and increased Drp1 levels 48 h after gene induction. Functionally, these cells exhibited lower mitochondrial membrane potential, reduced ATP pr
SUBMITTER: Fan RZ
PROVIDER: S-EPMC6862865 | biostudies-literature | 2019 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA